Headquartered in New York City, the client is one of the world’s largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. With a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, it manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
The client was trying to build an ecosystem of cloud-native applications with standardized CFT templates and automated deployment. The client needed to drive agility, security, and governance across their platforms and the digital ecosystem. The new applications should enhance the control and improve standardization across the organization, boosting performance and significantly reducing the time to market.
Brillio started by building a DevOps pipeline based on AWS for speeding up the app development process and for enhancing business app provisioning.
We also leveraged our deep AWW expertise and built a product service catalog using Product Factory Framework in a HUB-SPOKE Model where products are getting distributed into multiple child accounts from a single service account with its product.
Following Brillio’s implementation, there was an immediate 35% reduction in cycle time for new deployments through DevOps automation, as well as a reduction in cycle time from 60 to 1.2 hours for compute-intensive clinical trial simulations.
Brillio also significantly improved the security by providing patched, hardened secure instances to all business units. We also provided 20+ starter kit templates for quick-service onboarding on the cloud created as part of the Service Catalog.
Let’s create something brilliant together!Let's Connect